NutraIngredients Omega-3 Summit

WATCH: Why omega-3 policy needs to keep pace with research around pregnancy benefits

By Gary Scattergood contact

- Last updated on GMT

Industry has a crucial role to play in educating policymakers about the maternal and prenatal benefits of omega-3 supplementation, on the back of new and "compelling evidence".

That's the view expressed in this exclusive video interview with DSM's Dr Femke Hannes, who was a keynote speaker at the recent NutraIngredients Omega-3 Summit in Singapore.

In the video, she recaps some of the key takeaways from her talk,​ which referenced a recent Cochrane Review on the benefits of maternal omega-3 supplements in relation to reducing pre-term births.

Dr Hannes outlines the “staggering” extent of the problem, and underlines the importance of encouraging policymakers to create new guidelines and recommendations on the back of the research.

She also discusses the positive role that can be played by omega-3 index testing, where DSM has recently collaborated with OmegaQuant​ to create a product tailor-made for pregnant women.

Take a look at the video for more.

Related news

Show more

Related products

show more

Gemini Pharmaceuticals and Transparency

Gemini Pharmaceuticals and Transparency

Gemini Pharmaceuticals | 01-Sep-2019 | Application Note

The industry has shown improvement in its transparency in the past 5 years. Per the regulations, a Brand Owner is 100% responsible for the quality of...

The Elegance of Expeller Pressed

The Elegance of Expeller Pressed

Bunge Oils | 22-May-2019 | Technical / White Paper

Simply put: today’s consumers want food, simply. Shoppers are choosing products with fewer ingredients that are closer to the fresh foods they know. One...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars